SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA TO FLUOROQUINOLONES FOLLOWING 4 YEARS OF USE IN A TERTIARY CARE HOSPITAL

被引：11

作者：

SHALIT, I ^{[1
]}

HAAS, H ^{[1
]}

BERGER, SA ^{[1
]}

机构：

[1] TEL AVIV SOURASKY MED CTR,DEPT MICROBIOL,TEL AVIV,ISRAEL

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1992年 / 30卷 / 02期

关键词：

D O I：

10.1093/jac/30.2.149

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Of 121 recent clinical isolates of Pseudomonas aeruginosa, 22% were resistant to ciprofloxacin, 50% to ofloxacin and 69% to pefloxacin. Resistance to these drugs was commonest among urinary isolates (P<0-03). Cross-resistance was noted between fluoroquinolones and aminoglycosides or β-lactams. © 1992 The British Society for Antimicrobial Chemotherapy.

引用

页码：149 / 152

页数：4

共 11 条

[1] CIPROFLOXACIN DISK SUSCEPTIBILITY TESTS - INTERPRETIVE ZONE SIZE STANDARDS FOR 5-MU-G DISKS [J].

BARRY, AL ;

FASS, RJ ;

ANHALT, JP ;

NEU, HC ;

THORNSBERRY, C ;

TILTON, RC ;

PAINTER, BG ;

WASHINGTON, JA .

JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (06) :880-883

[2] CHARACTERIZATION OF MECHANISMS OF QUINOLONE RESISTANCE IN PSEUDOMONAS-AERUGINOSA STRAINS ISOLATED INVITRO AND INVIVO DURING EXPERIMENTAL ENDOCARDITIS [J].

CHAMBERLAND, S ;

BAYER, AS ;

SCHOLLAARDT, T ;

WONG, SA ;

BRYAN, LE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :624-634

[3] OFLOXACIN SUSCEPTIBILITY TESTING QUALITY-CONTROL PARAMETERS FOR MICRODILUTION AND DISK DIFFUSION, AND CONFIRMATION OF DISK DIFFUSION INTERPRETIVE CRITERIA [J].

FUCHS, PC ;

JONES, RN ;

BARRY, AL ;

GAVAN, TL .

JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (01) :49-52

[4] TENTATIVE DISK DIFFUSION SUSCEPTIBILITY INTERPRETIVE CRITERIA FOR PELOXACIN [J].

FUCHS, PC ;

BARRY, AL ;

JONES, RN ;

THORNSBERRY, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (03) :448-450

[5] CROSS-RESISTANCE TO NALIDIXIC-ACID, TRIMETHOPRIM, AND CHLORAMPHENICOL ASSOCIATED WITH ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF KLEBSIELLA, ENTEROBACTER, AND SERRATIA [J].

GUTMANN, L ;

WILLIAMSON, R ;

MOREAU, N ;

KITZIS, MD ;

COLLATZ, E ;

ACAR, JF ;

GOLDSTEIN, FW .

JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :501-507

[6] DEVELOPMENT OF RESISTANCE TO NALIDIXIC-ACID AND THE FLUOROQUINOLONES AFTER THE INTRODUCTION OF NORFLOXACIN AND OFLOXACIN [J].

KRESKEN, M ;

WIEDEMANN, B .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1285-1288

[7] RESISTANCE TO PEFLOXACIN IN PSEUDOMONAS-AERUGINOSA [J].

MICHEAHAMZEHPOUR, M ;

LUCAIN, C ;

PECHERE, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :512-518

[8] ASSOCIATION WITH PRIOR FLUOROQUINOLONE THERAPY OF WIDESPREAD CIPROFLOXACIN RESISTANCE AMONG GRAM-NEGATIVE ISOLATES IN A VETERANS AFFAIRS MEDICAL-CENTER [J].

MUDER, RR ;

BRENNEN, C ;

GOETZ, AM ;

WAGENER, MM ;

RIHS, JD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) :256-258

[9] SELECTION OF MULTIPLE ANTIBIOTIC-RESISTANCE BY QUINOLONES, BETA-LACTAMS, AND AMINOGLYCOSIDES WITH SPECIAL REFERENCE TO CROSS-RESISTANCE BETWEEN UNRELATED DRUG CLASSES [J].

SANDERS, CC ;

SANDERS, WE ;

GOERING, RV ;

WERNER, V .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (06) :797-801

[10] CROSS RESISTANCE TO CIPROFLOXACIN AND OTHER ANTIMICROBIAL AGENTS AMONG CLINICAL ISOLATES OF ACINETOBACTER-CALCOACETICUS BIOVAR ANITRATUS [J].

SHALIT, I ;

DAN, M ;

GUTMAN, R ;

GOREA, A ;

BERGER, SA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (03) :494-495

← 1 2 →